

| · | Most impo | rtant | sy | mptoms | an | d | effects, | both | acute | and del | ayed | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No further | releva | nt | informatio | n | av | ailable. | ||||||
| · | Indication | of an | y i | mmediat | e | me | dical att | entio | n and | special | treatment | needed |
| No further | releva | nt | informatio | n | av | ailable. |
| HEALTH | 0 | Poses no health hazard, no precautions necessary and would offer no hazard beyond that of ordinary combustible materials | |
| FIRE | 3 | Liquids and solids (including finely divided suspended solids) that can be ignited under almost all ambient temperature conditions . Liquids having a flash point below 22.8 °C (73 °F) and having a boiling point at or above 37.8 °C (100 °F) or having a flash point between 22.8 and 37.8 °C (73 and 100 °F). (e.g. gasoline, acetone) | |
| REACT | 0 | Normally stable, even under fire exposure conditions, and is not reactive with water (e.g. helium,N2) | |
| SPEC. HAZ. |
| 67-56-1 Methanol | |
|---|---|
| PEL | Long-term value: 260 mg/m³, 200 ppm |
| REL | Short-term value: 325 mg/m³, 250 ppm Long-term value: 260 mg/m³, 200 ppm Skin |
| TLV | Short-term value: 328 mg/m³, 250 ppm Long-term value: 262 mg/m³, 200 ppm Skin; BEI |
| Ingredients with biological limit values: | |
| 67-56-1 Methanol | |
|---|---|
| BEI | 15 mg/L Medium: urine Time: end of shift Parameter: Methanol (background, nonspecific) |
| Substance / Estimate | Route | Endpoint | Value |
|---|---|---|---|
| ATE (Acute Toxicity Estimate) | Oral | LD50 | 100 mg/kg (rat) |
| ATE (Acute Toxicity Estimate) | Dermal | LD50 | 300 mg/kg (rabbit) |
| ATE (Acute Toxicity Estimate) | Inhalative | LC50/4 h | 3.08 mg/l (rat) |
| 67-56-1 Methanol | Oral | LD50 | 100.1 mg/kg (rat) (Expert judgment) Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2) Symptoms: Nausea, Vomiting |
| 67-56-1 Methanol | Dermal | LD50 | 300.1 mg/kg (rabbit) (Expert judgment) Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2) |
| 67-56-1 Methanol | Inhalative | LC50/4 h | 3.1 mg/l (rat) (Expert judgment) Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2) Symptoms: Irritation symptoms in the respiratory tract. |
| 57-27-2 Morphine | Oral | LD50 | 335 mg/kg (rat) |
| 57-27-2 Morphine | Oral | TDLO | 3,857 µg/kg/1W intermittent (man) |
| 57-27-2 Morphine | Intraperitoneal | LD50 | 100 mg/kg (rat) |
| 57-27-2 Morphine | Subcutaneous | LD50 | 220 mg/kg (mouse) |
| Section 355 (extremely hazardous substances): | None of the ingredients is listed. |
| Section 313 (Specific toxic chemical listings): | 67-56-1 Methanol |
| TSCA (Toxic Substances Control Act): | 67-56-1 Methanol ACTIVE |
| Hazardous Air Pollutants 67-56-1 Methanol | |
| Chemicals known to cause cancer: | None of the ingredients is listed. |
| Chemicals known to cause reproductive toxicity for females: | None of the ingredients is listed. |
| Chemicals known to cause reproductive toxicity for males: | None of the ingredients is listed. |
| Chemicals known to cause developmental toxicity: | 67-56-1 Methanol |
| EPA (Environmental Protection Agency): | None of the ingredients is listed. |
The information in this MSDS is only applicable to the specified product, unless otherwise specified, it is not applicable to the mixture of this product and other substances. This MSDS only provides information on the safety of the product for those who have received the appropriate professional training for the user of the product. Users of this MSDS must make independent judgments on the applicability of this SDS. The authors of this MSDS will not be held responsible for any harm caused by the use of this MSDS.